Ligand-independent activation of c-Met by fibronectin and α5 Β1-integrin regulates ovarian cancer invasion and metastasis

Anirban Mitra, K. Sawada, P. Tiwari, K. Mui, K. Gwin, E. Lengyel

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

The role of the fibronectin receptor, α 5 Β 1-integrin, as an adhesion receptor and in angiogenesis is well established. However, its role in cancer cell invasion and metastasis is less clear. We describe a novel mechanism by which fibronectin regulates ovarian cancer cell signaling and promotes metastasis. Fibronectin binding to α 5 Β 1-integrin led to a direct association of α 5-integrin with the receptor tyrosine kinase, c-Met, activating it in a hepatocyte growth factor/scatter factor (HGF/SF) independent manner. Subsequently, c-Met associated with Src, and activated Src and focal adhesion kinase (FAK). Inhibition of α 5 Β 1-integrin decreased the phosphorylation of c-Met, FAK and Src, both in vitro and in vivo. Independent activation of c-Met by its native ligand, HGF/SF, or overexpression of a constitutively active FAK in HeyA8 cells could overcome the effect of α 5 Β 1-integrin inhibition on tumor cell invasion, indicating that α 5 Β 1-integrin is upstream of c-Met, Src and FAK. Inhibition of α 5 Β 1-integrin on cancer cells in two xenograft models of ovarian cancer metastasis resulted in a significant decrease of tumor burden, which was independent of the effect of α 5 Β 1-integrin on angiogenesis. These data suggest that fibronectin promotes ovarian cancer invasion and metastasis through an α 5 Β 1-integrin/c-Met/FAK/Src-dependent signaling pathway, transducing signals through c-Met in an HGF/SF-independent manner.

Original languageEnglish (US)
Pages (from-to)1566-1576
Number of pages11
JournalOncogene
Volume30
Issue number13
DOIs
StatePublished - Mar 31 2011
Externally publishedYes

Fingerprint

Fibronectins
Integrins
Ovarian Neoplasms
Hepatocyte Growth Factor
Focal Adhesion Protein-Tyrosine Kinases
Neoplasm Metastasis
Ligands
Integrin alpha5beta1
Proto-Oncogene Proteins c-met
Neoplasms
Tumor Burden
Heterografts
Signal Transduction
Phosphorylation

Keywords

  • αβ-integrin
  • c-Met
  • FAK
  • fibronectin
  • ovarian cancer
  • Src

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Ligand-independent activation of c-Met by fibronectin and α5 Β1-integrin regulates ovarian cancer invasion and metastasis. / Mitra, Anirban; Sawada, K.; Tiwari, P.; Mui, K.; Gwin, K.; Lengyel, E.

In: Oncogene, Vol. 30, No. 13, 31.03.2011, p. 1566-1576.

Research output: Contribution to journalArticle

Mitra, Anirban ; Sawada, K. ; Tiwari, P. ; Mui, K. ; Gwin, K. ; Lengyel, E. / Ligand-independent activation of c-Met by fibronectin and α5 Β1-integrin regulates ovarian cancer invasion and metastasis. In: Oncogene. 2011 ; Vol. 30, No. 13. pp. 1566-1576.
@article{ce961098818d4d958450341492319bb4,
title = "Ligand-independent activation of c-Met by fibronectin and α5 Β1-integrin regulates ovarian cancer invasion and metastasis",
abstract = "The role of the fibronectin receptor, α 5 Β 1-integrin, as an adhesion receptor and in angiogenesis is well established. However, its role in cancer cell invasion and metastasis is less clear. We describe a novel mechanism by which fibronectin regulates ovarian cancer cell signaling and promotes metastasis. Fibronectin binding to α 5 Β 1-integrin led to a direct association of α 5-integrin with the receptor tyrosine kinase, c-Met, activating it in a hepatocyte growth factor/scatter factor (HGF/SF) independent manner. Subsequently, c-Met associated with Src, and activated Src and focal adhesion kinase (FAK). Inhibition of α 5 Β 1-integrin decreased the phosphorylation of c-Met, FAK and Src, both in vitro and in vivo. Independent activation of c-Met by its native ligand, HGF/SF, or overexpression of a constitutively active FAK in HeyA8 cells could overcome the effect of α 5 Β 1-integrin inhibition on tumor cell invasion, indicating that α 5 Β 1-integrin is upstream of c-Met, Src and FAK. Inhibition of α 5 Β 1-integrin on cancer cells in two xenograft models of ovarian cancer metastasis resulted in a significant decrease of tumor burden, which was independent of the effect of α 5 Β 1-integrin on angiogenesis. These data suggest that fibronectin promotes ovarian cancer invasion and metastasis through an α 5 Β 1-integrin/c-Met/FAK/Src-dependent signaling pathway, transducing signals through c-Met in an HGF/SF-independent manner.",
keywords = "αβ-integrin, c-Met, FAK, fibronectin, ovarian cancer, Src",
author = "Anirban Mitra and K. Sawada and P. Tiwari and K. Mui and K. Gwin and E. Lengyel",
year = "2011",
month = "3",
day = "31",
doi = "10.1038/onc.2010.532",
language = "English (US)",
volume = "30",
pages = "1566--1576",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "13",

}

TY - JOUR

T1 - Ligand-independent activation of c-Met by fibronectin and α5 Β1-integrin regulates ovarian cancer invasion and metastasis

AU - Mitra, Anirban

AU - Sawada, K.

AU - Tiwari, P.

AU - Mui, K.

AU - Gwin, K.

AU - Lengyel, E.

PY - 2011/3/31

Y1 - 2011/3/31

N2 - The role of the fibronectin receptor, α 5 Β 1-integrin, as an adhesion receptor and in angiogenesis is well established. However, its role in cancer cell invasion and metastasis is less clear. We describe a novel mechanism by which fibronectin regulates ovarian cancer cell signaling and promotes metastasis. Fibronectin binding to α 5 Β 1-integrin led to a direct association of α 5-integrin with the receptor tyrosine kinase, c-Met, activating it in a hepatocyte growth factor/scatter factor (HGF/SF) independent manner. Subsequently, c-Met associated with Src, and activated Src and focal adhesion kinase (FAK). Inhibition of α 5 Β 1-integrin decreased the phosphorylation of c-Met, FAK and Src, both in vitro and in vivo. Independent activation of c-Met by its native ligand, HGF/SF, or overexpression of a constitutively active FAK in HeyA8 cells could overcome the effect of α 5 Β 1-integrin inhibition on tumor cell invasion, indicating that α 5 Β 1-integrin is upstream of c-Met, Src and FAK. Inhibition of α 5 Β 1-integrin on cancer cells in two xenograft models of ovarian cancer metastasis resulted in a significant decrease of tumor burden, which was independent of the effect of α 5 Β 1-integrin on angiogenesis. These data suggest that fibronectin promotes ovarian cancer invasion and metastasis through an α 5 Β 1-integrin/c-Met/FAK/Src-dependent signaling pathway, transducing signals through c-Met in an HGF/SF-independent manner.

AB - The role of the fibronectin receptor, α 5 Β 1-integrin, as an adhesion receptor and in angiogenesis is well established. However, its role in cancer cell invasion and metastasis is less clear. We describe a novel mechanism by which fibronectin regulates ovarian cancer cell signaling and promotes metastasis. Fibronectin binding to α 5 Β 1-integrin led to a direct association of α 5-integrin with the receptor tyrosine kinase, c-Met, activating it in a hepatocyte growth factor/scatter factor (HGF/SF) independent manner. Subsequently, c-Met associated with Src, and activated Src and focal adhesion kinase (FAK). Inhibition of α 5 Β 1-integrin decreased the phosphorylation of c-Met, FAK and Src, both in vitro and in vivo. Independent activation of c-Met by its native ligand, HGF/SF, or overexpression of a constitutively active FAK in HeyA8 cells could overcome the effect of α 5 Β 1-integrin inhibition on tumor cell invasion, indicating that α 5 Β 1-integrin is upstream of c-Met, Src and FAK. Inhibition of α 5 Β 1-integrin on cancer cells in two xenograft models of ovarian cancer metastasis resulted in a significant decrease of tumor burden, which was independent of the effect of α 5 Β 1-integrin on angiogenesis. These data suggest that fibronectin promotes ovarian cancer invasion and metastasis through an α 5 Β 1-integrin/c-Met/FAK/Src-dependent signaling pathway, transducing signals through c-Met in an HGF/SF-independent manner.

KW - αβ-integrin

KW - c-Met

KW - FAK

KW - fibronectin

KW - ovarian cancer

KW - Src

UR - http://www.scopus.com/inward/record.url?scp=79953220086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953220086&partnerID=8YFLogxK

U2 - 10.1038/onc.2010.532

DO - 10.1038/onc.2010.532

M3 - Article

C2 - 21119598

AN - SCOPUS:79953220086

VL - 30

SP - 1566

EP - 1576

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 13

ER -